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Nodamura virus (NoV) was the first isolated member of the Nodaviridae, and is the type species of the alphanodavirus
genus. The alphanodaviruses infect insects; NoV is unique in that it can also lethally infect mammals. Nodaviruses have
bipartite positive-sense RNA genomes in which RNA1 encodes the RNA-dependent RNA polymerase and the smaller genome
segment, RNA2, encodes the capsid protein precursor. To facilitate the study of NoV, we generated infectious cDNA clones
of its two genomic RNAs. Transcription of these NoV1 and NoV2 cDNAs in mammalian cells led to viral RNA replication,
protein synthesis, and production of infectious virus. Subgenomic RNA3 was produced during RNA replication and encodes
nonstructural proteins B1 and B2 in overlapping ORFs. Site-directed mutagenesis of these ORFs, followed by SDS–PAGE and
MALDI–TOF mass spectrometry analyses, showed synthesis of B1 and two forms of B2 (B2-134 and B2-137) during viral
replication. We also characterized a point mutation in RNA1 far upstream of the RNA3 region that resulted in decreased
RNA3 synthesis and RNA2 replication, and a reduced yield of infectious particles. The ability to reproduce the entire life cycleElsevier Science (USA)
INTRODUCTION
Nodamura virus (NoV) is the type species of the al-
phanodavirus genus of the Nodaviridae. This family of
small riboviruses with bipartite, positive-strand RNA ge-
nomes also includes Flock house virus (FHV), Black
beetle virus (BBV), Boolarra virus (BoV), and Pariacoto
virus (PaV). In addition to their intrinsic interest, these
viruses provide outstanding model systems for the study
of RNA replication, virus assembly, and 3D structure (Ball
and Johnson, 1998; Schneemann et al., 1998). All al-
phanodaviruses infect insects. NoV is unique in that it
can also infect suckling mice (Scherer and Hurlbut, 1967)
and suckling hamsters (Garzon and Charpentier, 1991),
resulting in paralysis and death. Thus, it is the first
arbovirus described that can be lethal for both mamma-
lian and invertebrate organisms (Bailey et al., 1975;
Scherer and Hurlbut, 1967). NoV RNA replication is more
thermostable than that of the other family members,
consistent with its infectivity for mice and hamsters (Ball
et al., 1992).
NoV (strain Mag115) has been isolated only once, from
an inapparent infection of Culex tritaeniorhynchus mos-
quitoes during a screen for Japanese encephalitis virus
in 1956 in Japan. It was identified on the basis of its
lethality to suckling mice (Scherer and Hurlbut, 1967;
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436Scherer et al., 1968). NoV also lethally infects larvae of
the greater wax moth Galleria mellonella, adult honey-
bees (Apis mellifera), and several other mosquito spe-
cies, including Aedes aegypti, Ae. albopictus, Toxorhyn-
chites amboinensis and C. tarsalis (Bailey and Scott,
1973; Scherer and Hurlbut, 1967; Tesh, 1980). Pigs near
the site of NoV isolation had high levels of NoV neutral-
izing antibody, suggesting that they may be part of the
natural host range of this virus, but no positive human
antisera were detected (Scherer et al., 1968).
NoV infection of cultured baby hamster kidney BHK21
cells has been reported previously, although the results
were not consistently reproducible (Bailey et al., 1975;
Ball et al., 1992; Garzon et al., 1978; Hiscox and Ball,
1997; Newman and Brown, 1977; Newman et al., 1978).
Infected BHK21 cells exhibit no cytopathic effect (CPE),
but they could be used to grow stocks of infectious virus
(Bailey et al., 1975; Garzon et al., 1978; Newman and
Brown, 1977). However, analysis of NoV infection in
these cells focused entirely on quantitation of infectivity
rather than on RNA replication. When introduced by
transfection, purified NoV genomic RNAs can replicate in
BHK21 cells and a wide range of other cultured mamma-
lian cells (Ball et al., 1992).
Many of the features of the nodavirus replication cycle
have been established by studies of FHV and BBV (re-
viewed by Ball and Johnson, 1998). Infectious cDNA
clones have long been available for FHV (Dasmahapatraof this unusual nodavirus from cDNA clones will facilitate fu
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et al., 1986) and have recently been constructed for PaV
(Johnson and Ball, 2001; Johnson et al., 2000) and for therther a
betanodavirus Striped Jack nervous necrosis virus
(SJNNV; Iwamoto et al., 2001).
The nodavirus divided genome naturally separates the
replicative and packaging functions onto two different
positive-sense RNA molecules, RNA1 and RNA2, respec-
tively. Nodavirus genomic RNAs have 5 cap structures,
while their 3 ends lack poly(A) tails and are blocked to
chemical and enzymatic modification (Dasmahapatra et
al., 1985; Guarino et al., 1984; Kaesberg et al., 1990;
Newman and Brown, 1976). RNA1 and RNA2 are co-
packaged into the same virion and both are required for
infectivity (Newman and Brown, 1977). RNA1 encodes
protein A, the catalytic subunit of the RNA-dependent
RNA polymerase (RdRp) that replicates both genome
segments. RNA2 encodes the viral capsid protein pre-
cursor, , which is cleaved during maturation of the
particle into the  and  proteins found in the virion; this
cleavage is essential for infectivity (Schneemann et al.,
1992).
During RNA replication, the RdRp also directs the
production of subgenomic RNA3, which is 3-coterminal
with RNA1. FHV RNA2 and RNA3 are counter-regulatory.
FHV RNA2 replication depends on RNA3 synthesis but
not on the proteins RNA3 encodes, suggesting a role for
RNA3 in the coordination of FHV RNA replication (Eck-
erle and Ball, 2002). In contrast, RNA3 synthesis is sup-
pressed by the replication of RNA2 (Zhong and Rueckert,
1993).
BBV RNA3 (and the identical RNA3 of FHV) encodes
two small nonstructural proteins, B1 and B2, in overlap-
ping reading frames (Dasmahapatra et al., 1985). Previ-
ously, only a single RNA3-encoded protein was detected
for NoV and PaV, although both B1 and B2 ORFs are
present (Ball et al., 1992; Johnson and Ball, 2001; Johnson
et al., 2001a). The function of B1 remains unknown and
both BoV and SJNNV lack the B1 ORF altogether (Harper,
1994; Iwamoto et al., 2001). The FHV B2 protein was
shown recently to suppress RNA silencing in plants and
cultured Drosophila cells (Li et al., 2002) and is required
for wild-type levels of viral replication in Drosophila cells
(Harper, 1994; Li et al., 2002). However, both B2 and B1
are dispensable for FHV RNA replication in mammalian
and yeast cells (Ball, 1995; Price et al., 2000).
We recently reported the sequence of a full-length
cDNA clone of NoV RNA1 and compared it to the RNA1
segments of five other nodaviruses, an analysis that
revealed the extent of sequence and structural homology
among the encoded RdRp’s (Johnson et al., 2001a). A
sequence of NoV RNA2 lacking only the 3-terminal dinu-
cleotide has also been published (Dasgupta and Sgro,
1989).
We report here the construction and characterization
of full-length cDNA clones for NoV RNA1 and RNA2.
When these clones were transcribed from T7 promoters
in BSR T7/5 cells, BHK21 derivatives that constitutively
express T7 RNA polymerase (Buchholz et al., 1999), we
reproduced the entire viral infectious cycle, including
replication of the genomic RNAs, synthesis of sub-
genomic RNA3 and viral proteins, and assembly of NoV
particles. The infectivity of these particles was assayed
in G. mellonella larvae and in BHK21 cells. Mutation of
the NoV B1 and B2 ORFs followed by SDS–PAGE and
matrix-assisted laser desorption/ionization-time-of-flight
(MALDI–TOF) mass spectrometry (MS) analyses showed
that B1 was expressed along with two forms of the B2
protein, B2–134 and B2–137.
RESULTS
Determination of terminal sequences and
construction of full-length cDNA clones of NoV
genomic RNAs
NoV (Mag115 strain, ATCC) was grown in suckling
mice and passaged once in infected G. mellonella lar-
vae. Genomic RNAs isolated from these gradient-purified
NoV particles were used as templates for first strand
cDNA synthesis using random, and later NoV RNA1-
specific, primers. These initial clones lacked the extreme
5 and 3 terminal sequences, which were determined as
follows. We transfected BHK21 and BSR T7/5 cells with
authentic NoV virion RNA (vRNA) as sources of intracel-
lular replicating RNAs that were then used as templates
for 5RACE, primer extension (PE), and junction RT-PCR
(see below).
We determined the 5 terminal sequences of NoV
RNA1 by 5RACE (Table 1) and PE (Fig. 1), using as
templates total cellular RNA isolated from vRNA-trans-
fected BHK21 or BSR T7/5 cells, respectively. For RNA1,
TABLE 1
Sequences of the 5 and 3 Termini of NoV Genomic RNAs
Genomic
RNA Method
RNA sequencea
(5-to-3)
Number
of clones
NoV RNA1 5 RACEb,c (G)n UAUU . . . 9/9
d
Junction RT-PCRc GUAUU . . . GUGGU 5/6e
NoV RNA1 Consensus GUAUU . . . GUGGU
NoV RNA2 Junction RT-PCR f GUAAA . . . UUGGU 5/6g
NoV RNA2 Consensus GUAAA . . . UUGGU
a The junction RT-PCR sequences were separated into the corre-
sponding 5 and 3 termini for clarity, using the results of the PE (Fig. 2)
and 5 RACE analyses as a guide. The 5 end of RNA2 is as described
previously (Dasgupta and Sgro, 1989).
b,c Template consisted of (b) vRNA from an NoV stock grown in G.
mellonella larvae or (c) total cellular RNA from BHK21 cells transfected
with this vRNA.
d The same sequence was found with both templates (b) and (c), in
5/5 and 4/4 clones, respectively.
e 1/6 RNA1 clones had an extra C residue at the dimer junction.
f Template RNA consisted of vRNA from an NoV stock grown in
suckling mice.
g 1/6 RNA2 clones had a large deletion at the dimer junction.
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the 5 terminal sequence was 5GUAUU. . .3 (Table 1
and Fig. 1, top panel). The 5 end of subgenomic RNA3
was 5GUGUA. . .3 (Fig. 1, middle panel), which mapped
the RNA3 start site to nt 2732 of RNA1 (Johnson et al.,
2001a; Johnson et al., 2001b). For RNA2, PE analysis (Fig.
1, bottom panel) confirmed the 5 terminal sequence of
5GUAAA. . .3 (Dasgupta and Sgro, 1989). Replication of
the functional NoV cDNA clones in BSR T7/5 cells (see
below) produced RNAs with authentic 5 ends; the cor-
responding PE products co-migrated with those detected
after vRNA transfection (Fig. 1).
For each RNA, PE products 1 nt longer than the au-
thentic 5 termini were also observed (Fig. 1). Similar 1
products are detected for FHV RNAs (Ball, 1995; Ball and
Li, 1993) and likely represent reverse transcriptase ex-
tending onto their 5 cap structures, as previously de-
scribed (Davison and Moss, 1989). To determine directly
whether the1 species did correspond to 5 caps, RNAs
from BSR T7/5 cells transfected with both genomic
clones were treated with tobacco acid pyrophosphatase
(TAP) to remove cap structures and subjected to PE
analysis. For RNA2, we observed a decreased amount of
the 1 product upon TAP treatment, and a concomitant
increase in the amount of the expected product (Fig. 1,
Lanes 6 and 7), confirming that NoV RNA2 was capped,
consistent with an earlier report (Kaesberg et al., 1990).
The TAP treatment had a less profound effect on RNAs 1
and 3 (data not shown), perhaps because of the lower
abundance of the RNA1 and RNA3 species at the 1
position (Fig. 1). Nevertheless, we interpret these 1
RNA species as RNA1 and RNA3 with 5 caps as shown
for NoV RNA2.
The 3 terminal sequences of both genomic RNAs
were determined by reverse transcription polymerase
chain reaction (RT-PCR) on RNA homodimers, rather than
by conventional methods, because the 3 ends of single-
stranded nodavirus RNAs are blocked to chemical and
enzymatic modification (Dasmahapatra et al., 1985;
Guarino et al., 1984; Kaesberg et al., 1990). Again using
total cellular RNA from vRNA-transfected BHK21 cells as
a template, we amplified 3-5 junctions of negative
strand copies of head-to-tail dimers of RNA1 and RNA2
that arise naturally during RNA replication (Albarin˜o et
al., 2001; Johnson et al., 2000) and determined the se-
quences of 6 independent junction clones for each (Ta-
ble 1). For clarity of presentation in Table 1, these se-
quences have been separated into their corresponding
5 and 3 termini using the 5 terminal sequences deter-
mined above (Table 1 and Fig. 1). For RNA1, the consen-
sus 3 terminal sequence was 5. . .GUGGU3. RT-PCR
across dimer junctions also allowed us to complete the
3 terminal sequence of NoV RNA2. Originally reported
FIG. 1. Mapping of the 5 termini of NoV genomic and subgenomic RNAs. BSR T7/5 cells, which constitutively express T7 RNA polymerase
(Buchholz et al., 1999), were transfected with NoV vRNA or with functional clones of NoV RNA1 and RNA2, either alone or in combination. Total cellular
RNAs were isolated and analyzed by PE, using primers specific for NoV RNA1 (top), RNA3 (middle), or RNA2 (bottom). PE products were separated
on a 5%-polyacrylamide sequencing gel along with sequencing ladders generated with the same primers and plasmid DNA templates. The NoV
genome organization is shown schematically at left. Left panels: Transfection with vRNA (Lane 1), pNoV1(0,0) alone (Lane 2) or together with
pNoV2(0,0) (Lane 3), pNoV2(0,0) alone (Lane 4), or mock transfection (Lane 5). Right panel: Transfection with pNoV1(0,0) and pNoV2(0,0) as above.
Total cellular RNAs were treated with TAP to remove 5 cap structures (Lane 6), or mock treated (Lane 7) prior to PE using the RNA2 primer.
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as 5. . .UUGX3 (Dasgupta and Sgro, 1989), we found the
complete sequence to be 5. . .UUGGU3 (Table 1).
Full-length cDNAs of NoV RNA1 and RNA2 were syn-
thesized by RT-PCR, using primers whose sequences
were derived from the consensus termini shown in Table
1, and ligated into transcription plasmid TVT7R(0,0) (John-
son et al., 2000). The resulting plasmids, pNoV1(0,0) and
pNoV2(0,0), contained the general sequence arrange-
ment 5-T7 promoter-NoV cDNA-HDV ribozyme cDNA-T7
terminator-3. The 5 ends of the primary T7 transcripts
are defined by promoter positioning and their 3 ends by
ribozyme cleavage (Ball, 1994). The (0,0) nomenclature
follows our previous convention, where the numbers in
parentheses represent the number of extraneous nucle-
otides at the 5 and 3 termini, respectively, of the final
ribozyme-cleaved transcript (Ball and Li, 1993). Unlike
cDNA clones of FHV and PaV RNA1 (Ball, 1995; Johnson
and Ball, 2001), pNoV1(0,0) required no extraneous nu-
cleotides between the T7 promoter and the first nucleo-
tide of the NoV RNA1 cDNA to direct efficient primary T7
transcription and subsequent RNA replication in BSR
T7/5 cells.
The cDNA inserts of these clones were sequenced.
Detailed analysis of the NoV RNA1 cDNA sequence and
its comparison to the RNA1 sequences of five other
nodaviruses has been published elsewhere (Johnson et
al., 2001a). NoV RNA1 is 3204 nt in length and the
organization of its open reading frames (ORFs) is typical
of the Nodaviridae.
RNA2 is 1336 nt in length and encodes protein , the
capsid protein precursor (Dasgupta and Sgro, 1989). In
addition to the GU dinucleotide at the 3 end (Table 1, see
above), the sequence of the NoV RNA2 cDNA clone
differs from the published RNA2 sequence (Accession
number X15961; Dasgupta and Sgro, 1989) at the follow-
ing positions, with the effects on the protein  coding
region shown in parentheses: G328U (silent), C854G and
G855C (Arg279Ala), A1196G (Thr393Ala), C1292U (3
UTR). The mass of protein  as determined by MALDI–
TOF MS is consistent with an alanine at position 393 in
our preparation of the NoV Mag115 field isolate (Johnson
et al., 2000).
RNA replication in mammalian cells expressing T7
RNA polymerase
Our laboratory has previously developed technology
for the in vivo production of replication-competent pri-
mary T7 transcripts of FHV and PaV genomic RNAs
(Albarin˜o et al., 2001; Johnson and Ball, 2001). This sys-
tem relies on transfection of DNA plasmids into BSR T7/5
cells, which express T7 RNA polymerase (Buchholz et al.,
1999). Plasmids pNoV1(0,0) and pNoV2(0,0) were trans-
fected alone or together into BSR T7/5 cells. At 48 h
post-transfection, the products of the viral RdRp were
labeled for 3 h with [3H]uridine in the presence of acti-
nomycin D as described in Materials and Methods and
separated on a denaturing agarose gel (Fig. 2). On trans-
fection of pNoV1(0,0) alone we detected an RNA replica-
tion product (Fig. 2, Lane 3) that co-migrated with au-
thentic RNA1 produced on transfection with vRNA (Fig. 2,
Lane 1). We also detected synthesis of subgenomic
RNA3, another indicator of nodavirus RNA replication.
On co-transfection of both genomic clones, RNA2 was
replicated and RNA3 production was down regulated
(Fig. 2, Lane 7), as expected from a previous report (Ball
et al., 1992). We also observed RNA2-mediated suppres-
sion of RNA3 synthesis by PE analysis (Fig. 1, middle
panel, compare Lanes 1 and 2). Suppression of NoV
RNA3 was consistently less severe than that seen with
FHV, such that a residual level of RNA3 was observed
even in the presence of RNA2 replication (Fig. 2 and data
not shown). The RNA2 derived from the cDNA clone
co-migrated with authentic NoV RNA2 produced on
vRNA-transfection (Fig. 2, compare Lanes 1 and 7). When
pNoV2(0,0) was transfected alone, no RNA replication
was observed (Fig. 2, Lane 6) and we detected no pri-
mary RNA2 T7 transcripts by PE (Fig. 1, bottom panel,
Lane 4), attesting to the low abundance of RNA2 in the
absence of RNA replication. The recombinant RNAs rep-
licated with similar efficiencies at 28°C, 31°C, and 34°C
(data not shown). They also replicated at 37°C at a
greatly reduced rate, as previously described for NoV
vRNA (Ball et al., 1992).
During construction of the NoV RNA1 cDNA clone, we
discovered a mutant cDNA that produced less RNA3
FIG. 2. RNA replication in mammalian cells transfected with NoV1
and NoV2 cDNA clones. BSR T7/5 cells were mock transfected (Lanes
2 and 6) or transfected with wild-type (Lanes 3 and 7) or mutant (Lanes
4, 5, 8 and 9) versions of pNoV1(0,0), either alone (Lanes 2–5) or
together with pNoV2(0,0) (Lanes 6–9) and incubated at 28°C for 48 h, or
transfected with vRNA (Lane 1) and incubated for 24 h. The products of
RNA replication were then labeled for 3 h by the metabolic incorpora-
tion of [3H]uridine in the presence of actinomycin D to inhibit DNA-
dependent RNA synthesis. Total cellular RNAs were isolated and sep-
arated on a denaturing formaldehyde-agarose gel; labeled RNAs were
detected by fluorography. The genotype of mutant 1, which lacks the
protein B2 ORF, is shown in Fig. 3A.
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than did the wild-type. Sequence analysis showed that
the mutant clone differed from pNoV1(0,0) at 13 nucleo-
tide positions. After introduction of these changes into
the wild-type sequence, we observed that the single
mutation U1274C reduced the RNA3:RNA1 ratio by 80%
relative to wild-type (Fig. 2, Lane 4). This mutation en-
coded a valine to alanine change at position 418 of the
RdRp. To determine whether the observed phenotype
was caused by this amino acid change, we separated
the RNA1 template and RdRp mRNA functions onto two
different RNAs expressed from separate T7 transcription
plasmids, as described for FHV (Ball, 1994; Eckerle and
Ball, 2002). The results indicated that a defect in the RNA
template, rather than in the RdRp, was responsible for
the phenotype (data not shown). The mutation at 1274 is
1458 nt upstream of the start site of RNA3, suggesting
the possibility of a long-range interaction between the
two regions (Johnson and Ball, 2000). This suggestion is
consistent with the observation that a similar region in
FHV RNA1 forms a base-pairing interaction with a region
just upstream of the RNA3 start site, and that this inter-
action enhances RNA3 synthesis (Lindenbach et al.,
2002).
Since the ability of FHV RNA2 to replicate is absolutely
dependent upon the presence of FHV RNA3 (Eckerle and
Ball, 2002), we compared the ability of the U1274C mutant
to support RNA2 replication with that of the wild-type
RNA1. The mutant RNA1 clone was also defective in its
ability to support replication of RNA2 in trans, synthesiz-
ing 70% less RNA2 than the wild-type RNA1 clone (Fig. 2,
compare Lanes 7 and 8). These data suggest that the
RNA3-dependent control mechanism proposed for coor-
dination of the replication of FHV genome segments may
extend to other alphanodaviruses.
Synthesis of small nonstructural proteins encoded by
NoV RNA3
Li et al. (2002) have recently shown that FHV B2 sup-
presses RNA silencing/interference, establishing for the
first time a possible function for this small nonstructural
protein. For this reason, we examined the translation
products of NoV RNA3 in some detail. The sequence of
NoV RNA3 reveals two overlapping ORFs (Johnson et al.,
2001a). That closest to the 5 end of RNA3 overlaps the
protein A ORF in the 1 reading frame and is predicted
to direct a primary translation product that contains 137
aa residues. However, the fourth codon in this ORF is
another AUG, and initiation here would yield a 134-
residue protein (Fig. 3A). The second ORF initiates at the
third AUG codon in RNA3 and represents the C-terminal
131 aa residues of protein A (Fig. 3A). By analogy with the
RNA3 ORFs in BBV, FHV, and PaV, we designated these
ORFs B2 and B1, respectively. To identify their translation
products, we mutated their initiation codons, either sin-
gly or in combination (Fig. 3A), and examined the small
nonstructural proteins that accumulated in plasmid-
transfected cells using SDS–PAGE, MALDI–TOF MS, and
peptide mapping of wild-type and mutant products.
An abundant viral protein with an Mr of about 15 kDa
accumulated in BSR T7/5 cells transfected with wild-type
pNoV1(0,0) (Fig. 3B, Lane 2), and to a lesser extent in
cells transfected with pNoV1(0,0)U1274C (Fig. 3B, Lane
3). On excision of the wild-type protein band from an
SDS–PAGE gel, MALDI–TOF MS analysis showed that it
contained two species. Subsequent MALDI–TOF analy-
sis of a wild-type-transfected cell lysate confirmed the
presence of two species (molecular masses 14595 and
14942 Da) that differed by 347 Da in mass (Fig. 4A); both
species were also detected in the U1274C-transfected
lysate (data not shown). The larger was eliminated by
mutation of the first AUG codon in RNA3 (mutant 4; Fig.
4D) whereas the smaller was eliminated by mutation of
the second AUG codon (mutant 2; Fig. 4C). Both proteins
were eliminated by the double mutation (mutant 1; Fig.
3B, Lane 4, and Fig. 4B). Furthermore, the individual
15-kDa proteins produced by mutants 2 and 4 both
yielded B2-specific tryptic peptides, which identified
them as the products of translation of the B2 ORF, al-
though their distinctive N-terminal peptides were not
detected (data not shown). Accordingly, we refer to these
proteins as B2–137 and B2–134.
A new protein with an apparent Mr of 20 kDa accumu-
lated in cells transfected with the mutant 1 version of
pNoV1(0,0) (Fig. 3B, Lane 4). Upon excision from the gel,
trypsin digestion, and MALDI–TOF MS analysis, the NoV
protein yielded the B1-specific tryptic peptides shown in
Table 2. Gel purification of the protein before digestion
allowed us to distinguish B1-derived peptides from those
derived from the 116-kDa protein A.
Genetic analyses confirmed the identification of the
20-kDa protein as the translation product of the B1 ORF.
In mutants 3–5, the AUG at the start of the B1 ORF was
changed to CUG (Fig. 3A). Despite the unavoidable in-
troduction of a M913L mutation in protein A, these mu-
tants exhibited wild-type rates of RNA replication when
assayed by metabolic labeling (data not shown), show-
ing that this mutation had no major effect on RdRp
activity. However, elimination of the B1 AUG rendered the
20-kDa species undetectable by SDS–PAGE (Fig. 3B,
Lanes 6–8) and by MALDI–TOF MS and tryptic peptide
analyses (Table 2). Proteins B2–137, B2–134, and B1
were not made during replication of mutant 5, in which
both B2 and B1 ORFs were eliminated (Fig. 3B, Lane 8).
Compared to the wild-type, protein B1 accumulated to
excess during replication of mutants 1 and 2 (Fig. 3B,
Lanes 4 and 5), presumably as a result of the altered
sequence context of the B1 AUG. However, lower levels
of B1-specific peptides were detected in cells trans-
fected with the wild-type NoV1 cDNA when the corre-
sponding 20-kDa region was excised from an SDS–PAGE
gel, digested with trypsin and analyzed by MALDI–TOF
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MS (Table 2). This observation indicates that some B1
was synthesized during replication of the wild-type
RNA1.
Mutations that disrupt the FHV B2 ORF have little
effect on RNA replication in BHK21 cells or in yeast (Ball,
1995; Price et al., 2000), although similar mutations re-
duce or inhibit FHV replication in Drosophila cells (Harp-
er, 1994; Li et al., 2002). We tested the effect of NoV
mutant 1 on RNA replication in BSR T7/5 cells and ob-
served no difference in the rates of RNA1 replication or
RNA3 synthesis, nor any effect on the ability to replicate
RNA2 in trans (Fig. 2, compare Lanes 5 and 9). Similar
results were observed for mutants 2–5 (data not shown),
suggesting that RNA replication in BSR T7/5 cells did not
require synthesis of proteins B2 or B1.
In summary, we conclude from these genetic and
biochemical analyses that the NoV B2 ORF yields abun-
dant proteins from both its first and second AUG codons
(B2–137 and B2–134 respectively). In addition to these
species, lower levels of protein B1 were detected during
wild-type NoV RNA1 replication. Previous to this work, B1
protein synthesis was confirmed only for FHV (Harper,
1994), where the B1 ORF initiates before that of B2
(Guarino et al., 1984). The functions of NoV B1 and B2
proteins remain to be determined.
Capsid protein synthesis
We examined synthesis of protein , the viral capsid
protein precursor, in transfected cells labeled with
[35S]methionine and [35S]cysteine using SDS–PAGE (Fig.
5) and Western blot analyses (data not shown). As a
control, we analyzed the protein content of non-recom-
binant NoV (Mag115) virions. We detected protein  (43
kDa) and the larger of the mature capsid proteins,  (38
kDa), by Coomassie staining and by autoradiography of
FIG. 3. Synthesis of small nonstructural proteins in transfected BSR T7/5 cells. Panel A: schematic of mutations affecting the RNA3-encoded ORFs.
Panel B: gel analysis of the resulting mutants. Cells were mock transfected (Lane 1) or transfected with wild-type (Lane 2) or mutant (Lanes 3–8)
versions of pNoV1(0,0) as indicated in the figure, and lysed at 48 h post-transfection. Proteins were separated on 12.5%-polyacrylamide-SDS gels and
visualized by staining with Coomassie brilliant blue. The migration of protein molecular weight markers are shown at left, while the positions of
nonstructural proteins B1, B2–137 and B2–134 are indicated at right.
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an [35S]-labeled virion preparation (Fig. 5, Lane 9). Both
proteins were immunoreactive with rabbit hyperimmune
serum raised against purified NoV (Gallagher, 1987). The
smaller cleavage product, protein  (4.6 kDa), was not
labeled because it contains no methionine or cysteine
residues (Dasgupta and Sgro, 1989; Johnson et al., 2000)
but a protein of the appropriate size was detected by
Western blot (data not shown).
In cells transfected with pNoV2(0,0) together with wild-
type, U1274C or mutant 1 pNoV1(0,0) plasmids, we de-
tected a protein that co-migrated with , at levels that
appeared similar by SDS–PAGE regardless of the geno-
type of the NoV1 species (Fig. 5, Lanes 6–8). Protein 
was not seen in mock-transfected cells (Fig. 5, Lane 1) or
in cells transfected with any of these pNoV1(0,0) plas-
mids alone (Fig. 5, Lanes 2–4) or with pNoV2(0,0) alone
(Fig. 5, Lane 5), consistent with the low abundance of the
NoV RNA2 primary transcript (Fig. 1). Relatively little
protein  was detected in transfected cell lysates by
Western blot, compared to , yet  was readily detected
in purified virions. We attribute the scarcity of  in freshly
prepared cell lysates to the slow cleavage of  into  
 which occurs predominantly during and after virus
purification (Zlotnick et al., 1994). However, the detection
of protein  by Western blot in cells co-transfected with
pNoV2(0,0) and either wild-type or mutant U1274C ver-
sions of pNoV1(0,0) (data not shown) suggested that at
least some capsid protein cleavage occurred.
Recovery of infectious virus from NoV cDNA clones
We tested for the presence of infectious recombinant
NoV in transfected BSR T7/5 cell lysates by injecting
them into larvae of the greater wax moth, G. mellonella.
NoV infection in G. mellonella larvae causes paralysis of
the hind-most segments, progressing to death within
7–14 days (Bailey et al., 1975; Garzon et al., 1990). These
larvae have been used as a test for infectivity of NoV
grown in a variety of host cells and animals and are more
sensitive to NoV infection than suckling mice (Bailey et
al., 1975).
Lysates from cells transfected with pNoV1(0,0) alone,
pNoV1(0,0) and pNoV2(0,0) together, or authentic vRNA,
were injected into larvae. Those that died or became
paralyzed within two days of the injection were likely
injured during injection and thus were removed from the
experiments. The remaining larvae (n) were scored for
mobility and size on Day 11. The larvae were separated
into three groups: healthy, paralyzed, or dead, according
to the criteria outlined in the footnote to Table 3. At no
point during the incubation were sick or paralyzed larvae
observed to recover either normal mobility or a normal
growth phenotype.
Larvae injected with lysates from cells transfected
with plasmids pNoV1(0,0) and pNoV2(0,0) together ex-
hibited paralysis of the hind-most segments that pro-
gressed during the course of the experiments. By Day 11,
none of the larvae remained healthy, 8 of 21 were para-
lyzed, and the rest were dead (Table 3). Similar results
were obtained with lysates from vRNA-transfected cells:
7 of 19 were paralyzed and 12 were dead (Table 3). A
similar pattern of infection was also observed when
FIG. 4. MALDI–TOF mass spectrometry analysis of small nonstruc-
tural proteins B2 and B1 confirmed synthesis of two forms of B2.
Concentrated lysates from wild-type- or mutant pNoV1(0,0)-transfected
cells or mock-transfected cells, were analyzed by MALDI–TOF MS as
described in Materials and Methods. Each spectrum was normalized to
a mock-infected cell protein of 14691 Da molecular mass and to the
relative intensity of the highest peak in panel D. Panels: A, wild-type; B,
Mutant 1; C, Mutant 2; D, Mutant 4; E, mock. Note that the B2–137
protein encoded by mutant 2 (panel C) contains an M to T change and
therefore has a different mass than the wild-type protein (panel A). The
molecular masses of several minor peaks were: a, 15073; b, 15044; c,
14806; d, 14902.
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larvae were injected with purified mouse-derived NoV
(data not shown). Most of the larvae injected with lysates
from mock transfected cells (28 of 30) remained healthy
over the course of the experiment, although two died
from unknown causes. When larvae were injected with
lysates from cells transfected with pNoV1(0,0) alone (Ta-
ble 3) or, in a single experiment, pNoV2(0,0) alone (data
not shown), the results were similar to those obtained
with mock-transfected lysates. Pre-treatment of the
pNoV1  pNoV2 lysate with RNaseA had no effect,
showing that the infectivity was due to infectious virus
rather than infectious RNA (data not shown); this exper-
iment was performed once in infected larvae, but was
repeated several times in BHK21 cells with identical
results (see below). We concluded that the NoV cDNA
clones directed the assembly of viral particles that were
infectious for G. mellonella larvae.
Infectivity of NoV for BHK21 cells and time course of
RNA replication
NoV was reported to be infectious for BHK21 cells, but
the literature suggests that these results were not con-
sistently reproducible (Bailey et al., 1975; Ball et al., 1992;
Garzon et al., 1978; Hiscox and Ball, 1997; Newman and
Brown, 1977; Newman et al., 1978). The NoV cDNA
clones allowed us to reexamine the issue of BHK21 cell
infectivity using the more sensitive technique of Northern
blot hybridization. We found that authentic, mouse-de-
rived NoV and recombinant NoV derived from the cDNA
clones were both infectious for BHK21 (Fig. 6) and BSR
T7/5 cells (data not shown), confirming the infectivity of
the cloned cDNAs. NoV infectivity in BHK21 cells was
resistant to treatment with RNaseA and could be neu-
tralized with a rabbit hyperimmune serum raised against
purified, mouse-derived NoV (data not shown).
The infectivity of NoV for BHK21 cells allowed us to
examine the accumulation of viral RNAs in NoV-infected
cells over a 12-day time course. Cells were infected with
1000 particles per cell of authentic NoV isolated from
infected suckling mice (Figs. 6A and 6B) or of recombi-
nant NoV grown in G. mellonella larvae (Figs. 6C and 6D),
and incubated for 12 days at 28°C. Cells were harvested
at 24 h intervals and total cellular RNAs were isolated
and analyzed by Northern blot hybridization using probes
specific for the positive (Figs. 6A and 6C) or negative
(Figs. 6B and 6D) strands of NoV RNAs 1, 2 and 3. NoV
TABLE 3
Infectivity of NoV cDNA-Transfected BSR T7/5 Cell Lysates in
G. mellonella Larvaea
Lysate nb Healthy Paralyzed Dead
Mock 30 28 0 2
pNoV1 21 18 0 3
pNoV1  pNoV2 21 0 8 13
vRNA 19 0 7 12
a Lysates of transfected cells were injected into groups of 12 larvae.
Larvae that died or became paralyzed within 2 days of injection were
removed from the experiment. The remaining larvae (n) were scored for
mobility and size on day 11: healthy larvae were mobile and increased
in size over the incubation period, paralyzed larvae exhibited difficulty
in locomotion and stunted growth, while the remaining larvae died.
b The results of three (mock transfection) or two experiments were
pooled for this analysis.
TABLE 2
Molecular Mass of NoV B1-Specific Tryptic Peptides Detected by MALDI-TOF MSa
B1 Tryptic Peptide Start aa End aa Predicted mass
Mass determined
by MALDI-TOF
RRPGPPAK 82 89 879 879
QQGSASVLR 35 43 946 946
AAPAAGVSSDEQPAHQTASR 48 66 1880 1881
ANQVTSSQAGAAGSGDASNDPNAHDR 5 30 2498 2499
a Mock-, wildtype- or mutant pNoV1(0,0)-transfected BSR T7/5 cell lysates were separated on SDS-PAGE gels. The B1 region of each lane was
excised and digested with trypsin. The resulting peptides were isolated; their masses were determined by MALDI-TOF MS and compared to those
of the tryptic peptides predicted from the B1 sequence. Peptides with identical masses were detected for wildtype pNoV1(0,0), mutant 1 and mutant
2, while no B1-specific peptides were detected for mock lysates or lysates from cells transfected with mutants 3–5, which lack the B1 ORF.
FIG. 5. Synthesis of NoV capsid proteins in transfected cells. BSR
T7/5 cells were transfected with wild-type and mutant pNoV1(0,0)
plasmids, either alone (Lanes 1–4) or together with pNoV2(0,0) (Lanes
5–8), as described for Fig. 2. At 48 h post-transfection, cells were
labeled by the metabolic incorporation of [35S]methionine and [35S]cys-
teine. Proteins were separated on a 12.5%-polyacrylamide-SDS gel and
labeled proteins that remained in the gel after electrophoretic transfer
to PVDF membranes were visualized by autoradiography (see Materi-
als and Methods). [35S]-labeled non-recombinant NoV virions were
used as a marker (Lane 9). The positions of viral capsid proteins  and
 are indicated at right.
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RNA from purified virions was included in the positive-
strand gels as a marker (Lane 1).
No viral RNA was detected at the time of infection
(Figs. 6A and 6C, Lane 2), or in mock-infected samples
that were incubated for 10 days (data not shown),
whereas we detected genomic RNA1 and RNA2 by 24 h
post-infection (p.i.; Figs. 6A and 6C, Lane 3). At 24 h p.i.,
we also detected subgenomic RNA3, which is synthe-
sized by the RdRp only during RNA replication, showing
that the genomic RNAs were replicating. Accumulation of
positive strand viral RNAs increased gradually over the
next 11 days (Fig. 6A, Lanes 3–13). Similar accumulation
of positive-strand RNAs was observed for the recombi-
nant NoV stock, although with slightly delayed kinetics
(Fig. 6C). We also detected the accumulation of negative
strand copies of RNAs 1, 2, and 3, confirming that RNA
replication was occurring in these cells (Figs. 6B and
6D). In addition, we observed homodimeric forms of NoV
RNAs 1, 2 and 3 (Fig. 6) like those described for FHV
RNAs (Albarin˜o et al., 2001); homodimers of both polari-
ties were detected, although they were more readily
visible in the negative strand blots (Figs. 6B and 6D).
Quantitation of the Northern blots allowed us to examine
the molar ratios of NoV RNA1 and RNA2 positive to
negative strands, which were approximately 100:1, con-
sistent with previous reports for FHV (Albarin˜o et al.,
2001).
The continuous synthesis of RNA3 throughout the 12
day time course of infection was unexpected (Fig. 6),
since we observed the expected shutoff of RNA3 synthe-
sis in the presence of RNA2 in BSR T7/5 cells transfected
with vRNA or with plasmids (Fig. 2). The shutoff was also
observed on transfection of BHK21 cells with NoV vRNA
(data not shown). The apparent discrepancy may be due
to technical differences between the two experiments: in
transfected cells we measured the rate of RNA3 synthe-
sis by metabolic labeling (Fig. 2), whereas in infected
cells we analyzed the accumulation of RNA3 by Northern
blot hybridization (Fig. 6). However, it is possible that
there is an inherent difference in an infectious cycle
initiated by infection from one initiated by transfection,
even of RNA isolated from purified virions. Further work
will be required to reconcile the two observations.
The susceptibility of BHK21 cells to NoV infection also
allowed us to quantitate the yield of infectious NoV
particles from transfected BSR T7/5 cells in the absence
of a plaque assay. We determined the viral yields using
an endpoint dilution assay in infected BHK21 cells, cou-
pled with Northern blot analysis using a probe specific
for the positive strands of RNAs 1, 2 and 3 (data not
shown). BSR T7/5 cells were transfected with pNoV2(0,0)
together with either wild-type pNoV1(0,0) or the U1274C
mutant; 5 d after infection cell lysates were prepared,
treated with RNaseA and used to infect BHK21 cells.
Infection of parallel wells with known quantities of gra-
dient-purified recombinant NoV isolated from G. mel-
lonella larvae generated a standard curve. According to
this assay, the yield of wild-type recombinant NoV from
plasmid-transfected BSR T7/5 cells was estimated to be
2.5  105 particles per cell. However, because the effi-
ciency of plasmid DNA transfection into these cells was
likely less than 100%, this figure is probably a significant
underestimate.
Recombinant U1274C particles were also infectious for
BHK21 cells, although the yield of infectivity was about
100-fold lower than that of wild-type particles, when mea-
sured by the same endpoint dilution assay. When ana-
lyzed by Northern blot at 5 d p.i., the ratio of RNA2 to
FIG. 6. Time course of NoV infection in BHK21 cells. Cells in parallel wells were infected with 1000 particles per cell of either authentic,
mouse-derived NoV (panels A and B), or recombinant NoV isolated from G. mellonella larvae (panels C and D), or mock infected (data not shown),
and incubated at 28°C for 12 days. Cells were harvested at 24 h intervals, starting at the time of infection. Total cellular RNAs were isolated, resolved
by electrophoresis on agarose-formaldehyde gels, and detected by Northern blot analysis using probes specific for the positive- (panels A and C)
or negative- (panels B and D) strands of NoV RNAs 1, 2, and 3. In each case exposure times were identical, but 5 times more RNA was loaded for
the detection of negative strands than for positive strands. Lane 1 contains 5 ng of authentic NoV vRNA in the positive-strand blots and was left blank
in the negative-strand blots.
444 JOHNSON, PRICE, AND BALL
RNA1 was reduced 70% compared to that of the wild-
type, showing that this virus had retained its mutant
phenotype in the infected cell (data not shown). We
confirmed the presence of the U1274C mutation in in-
fected cells by RT-PCR and sequencing of a 300 bp
region of the bulk RT-PCR product spanning nt 1274 (data
not shown).
DISCUSSION
The BSR T7/5 cell system reproduced many of the
features of NoV RNA replication observed after transfec-
tion of NoV vRNA into BHK21 cells (Ball et al., 1992). On
transfection of pNoV1(0,0) we observed autonomous rep-
lication of RNA1 and synthesis of subgenomic RNA3.
When pNoV1(0,0) and pNoV2(0,0) were co-transfected,
both genomic RNAs replicated and RNA3 synthesis was
down regulated by RNA2 (Fig. 2), as previously described
(Ball et al., 1992). RNA replication was maintained at a
high level for at least 6 days after transfection (data not
shown). We detected synthesis of viral nonstructural (Fig.
3B) and structural (Fig. 5) proteins and showed that
progeny virus particles were lethal for G. mellonella lar-
vae (Table 3) and infectious for BHK21 cells (Fig. 6). No
cytopathic effects were observed even at very late times
in infection; similar results were reported previously for
BHK21 cells infected with authentic NoV (Ajello, 1979;
Bailey et al., 1975).
Kinetics of RNA replication in infected or transfected
mammalian cells
The susceptibility of BHK21 cells for NoV allowed us to
examine RNA replication over a 12-day time course fol-
lowing infection with authentic, mouse-derived virus
(Figs. 6A and 6B) or with recombinant NoV grown in G.
mellonella larvae (Figs. 6C and 6D). Previous analyses of
NoV infection in BHK21 cells quantitated the resulting
infectivity and did not examine RNA replication (Bailey et
al., 1975). For both authentic NoV and recombinant NoV,
we first detected replication of genomic RNAs 1 and 2
and synthesis of subgenomic RNA3 at 24 h p.i., and
these RNA species accumulated over the next 11 days
(Figs. 6A and 6C). Negative strand copies of the genomic
RNAs were also detected at 24 h p.i., whereas the neg-
ative strand of RNA3 was first seen above the level of a
background band that migrated slightly slower than
RNA3 at about 3 d p.i. Accumulation of the negative
strands of all three RNAs also increased over the entire
time course of the experiment (Figs. 6B and 6D). Ho-
modimeric species of RNAs 1, 2, and 3 of both polarities
were seen beginning at about Day 4 and accumulated
with kinetics similar to those seen for the monomeric
species (Fig. 6). Similar molecules arise during replica-
tion of FHV and PaV RNA and represent perfect head-to-
tail dimers of RNAs 1, 2, and 3 (Albarin˜o et al., 2001;
Johnson and Ball, 2001). The function of these species is
unknown.
These kinetics of RNA replication were observed fol-
lowing infection at an m.o.i. of 1000 particles per cell.
Under these conditions most cells were likely infected,
even assuming a high particle-to-PFU ratio like that re-
ported for FHV (Schneemann et al., 1992). Perhaps the
protracted time course was due to the establishment of
a persistent infection in these cells. Indeed, a previous
report showed that mosquito Aedes aegypti and Ae.
albopictus cells infected with NoV produce infectious
virus 4–16 days p.i. and appear to become persistently
infected (Bailey et al., 1975).
Mouse-derived NoV appeared to replicate slightly
more robustly than the recombinant virus, particularly
early in the infection (Fig. 6, compare panels A and B with
panels C and D). It is possible that the slight differences
in the accumulation of RNA replication products between
these two virus stocks derives from differences in the
hosts from which they were isolated. The authentic virus
stock was prepared from the hind limbs of infected
suckling mice, whereas the recombinant virus stock was
prepared after injection of a transfected BSR T7/5 cell
lysate into G. mellonella larvae. The difference could also
be attributed to slight differences in the extraction meth-
ods used for these two sources of infected animal tissue,
as described in Materials and Methods. These possibil-
ities will be the subject of further examination.
The kinetics of RNA replication observed after trans-
fection of NoV vRNA into BHK21 cells (Ball et al., 1992), or
cDNA plasmids into BSR T7/5 cells (data not shown), are
quite different from those seen after NoV infection (Fig.
6). In vRNA-transfected cells synthesis of RNA1 is first
detected by metabolic labeling 3–5 h post-transfection
and that of RNA2 slightly later; replication of both RNAs
continues at a high rate until at least 23 h post-transfec-
tion. RNA3 synthesis was also detected by metabolic
labeling, but only during the first 13 h after transfection
(Ball et al., 1992).
In contrast, RNA replication initiated from cloned
cDNAs in BSR T7/5 cells was not detected by metabolic
labeling at 24 h. RNA replication reached its peak rate at
48 h and continued at a high rate for at least 4 more days
(data not shown). The faster kinetics observed after
vRNA transfection, also seen for FHV and PaV (Albarin˜o
et al., 2001; Johnson and Ball, 2001), may be attributed to
the delivery of capped, functional RNAs directly to the
cytoplasm where translation and RNA replication occurs.
Delivery of plasmid DNA to BSR T7/5 cells requires the
additional step of primary T7 transcription, which gener-
ates uncapped RNAs that are likely to be poor templates
for translation, before the RNAs can be amplified.
In infected cells, the gradual onset of RNA replication
may be due to infection of a non-native type of host cell
(i.e., BHK21 cells); this block is circumvented when the
infectious cycle is initiated by transfection. BSR T7/5
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cells, together with the BHK21 cells from which they were
derived (Buchholz et al., 1999), will allow us to study all of
these processes, from initiation of primary transcription
from cDNA clones through particle production to a sec-
ond round of infection, in a single cell type.
Coupling between RNA3 synthesis and RNA2
replication
A mutant RNA1 with a U to C substitution at position
1274 directed synthesis of only 20% as much RNA3 as did
the wild-type NoV1 clone (Fig. 2). This mutant also sup-
ported RNA2 replication at 30% of the wild-type level (Fig.
2), showing that there is a linkage between RNA3 syn-
thesis and RNA2 replication for NoV as described for
FHV (Eckerle and Ball, 2002). On co-transfection of BSR
T7/5 cells with the U1274C mutant and pNoV2(0,0) the
protein  capsid precursor was synthesized (Fig. 5) and
infectious virus was produced, although the yield of in-
fectivity was about 100-fold lower than that obtained with
the wild-type RNA1 clone. We speculate that this reduc-
tion in infectivity is related to the shortage of RNA2 rather
than of protein , but this remains to be determined.
The mechanism of RNA3 synthesis has not yet been
defined for any of the alphanodaviruses. However, se-
quences in FHV RNA1 that modulate RNA3 synthesis
include a region that spans the RNA3 start site (nt 2721
for FHV) by at least 10 nt upstream and several nt down-
stream and a second region nearly 100 nt upstream of
the RNA3 start site (Eckerle and Ball, 2002). It remains to
be determined whether the analogous positions in NoV
RNA1 will prove important for synthesis of its RNA3.
However, the results presented here (Fig. 3A) suggest a
role for a third region that encompasses nt 1274 in the
synthesis of NoV RNA3, despite its position 1458 nt
upstream of the RNA3 start site at nt 2732. This effect
suggests potential long-range interactions between this
region and sequences near the start of RNA3 (Johnson
and Ball, 2000). This suggestion is consistent with the
report that an analogous region in FHV forms a base-
paired interaction with a region immediately upstream of
the start of RNA3 that enhances RNA3 synthesis (Lin-
denbach et al., 2002). The computer-predicted secondary
structure described for the positive strand of FHV RNA1,
in which nt 1227–1232 pairs with complementary nt
2716–2711 (helix 1) and nt 1234–1239 pairs with nt 2520–
2515 (helix 2), is also predicted to form for the analogous
regions of the positive strand of NoV RNA1 (Lindenbach
et al., 2002). NoV nt 1274 lies just outside of the predicted
secondary structure.
Identification of small nonstructural proteins encoded
by NoV RNA3
The relationship between the B2 and B1 protein ORFs
encoded by NoV RNA3 and synthesis of these small
nonstructural proteins was deciphered using a combina-
tion of genetic analysis and MALDI–TOF MS (Figs. 3 and
4). We showed that two forms of protein B2 are synthe-
sized, although the 134 aa form appears by SDS–PAGE
analysis to be predominant, at least in transfected BSR
T7/5 cells (Fig. 3B). Because B2–137 and B2–134 differ by
only 3 aa we assume that their stabilities are similar.
Their second residues (T and S, respectively) are both
stabilizing according to the N-end rules for protein sta-
bility (Varshavshy, 1996).
The molecular masses we obtained for proteins B2–
137 and B2–134 by mass spectrometry (14942 Da and
14595 Da, respectively; Figs. 4A and 4D) differed from
one another by 347 Da, within 1 Da of the interval
predicted by the 3 aa difference between the two (MTN;
346 Da). Similarly, we obtained masses for the wild-type
(14942 Da) and mutant 2 (14912 Da) versions of B2–137
that differed by exactly the interval of 30 Da predicted by
the M to T mutation at position 4 (Figs. 3A, 4A and 4C).
This concordance gave us great confidence in the rela-
tive mass measurements we obtained, but the values
relative to the standard, apomyoglobin, were consistently
91–92 Da lower than predicted for both B2–137 (predict-
ed mass 15033) and B2–134 (predicted mass 14687).
These differences are likely due to post-translational
modifications such as removal of the N-terminal methi-
onine residue and the addition of one or more small
modifying groups. A previous report that only 1–5% of
purified FHV B2 protein was accessible to N-terminal
sequencing is consistent with the presence of an unde-
fined modifying group at its N-terminus (Harper, 1994).
The abundance of B2–134 in transfected cells was
somewhat surprising, since the B2–134 ORF initiated at
the second AUG codon in RNA3 (Fig. 3A), while the
ribosome-scanning model of translation initiation would
favor the first AUG codon (Kozak, 1999). These AUG
codons had equivalent flanking consensus translation
initiation sequences (Cavener and Ray, 1991; Kozak,
1999). It is possible that its position only 13 nt from the 5
end of RNA3 prevents the efficient recognition of the
B2–137 AUG (Kozak, 1991). However, we detected B2–
137 protein even in the wild-type case (Fig. 4A) and in the
absence of the B2–134 AUG, the B2–137 protein was up
regulated (Fig. 3B, Lanes 2 and 5), suggesting that the
proximity of the B2–137 AUG to the 5 end may not be
inhibitory. Perhaps there is a specific mechanism to
regulate the balance between the two forms of NoV B2.
This possibility remains to be investigated.
In view of the abundant synthesis of B2–137 and B2–
134 from the first two AUG codons in RNA3, translation of
the B1 ORF was unexpected, yet we detected low levels
of B1 protein even in wild-type-transfected cells. The B1
initiation codon is the third AUG in RNA3 and its se-
quence context for translation initiation is similar to
those of the B2 ORFs; only 2 nt separates the B1 AUG
from that of B2–134 (Fig. 3A). The observation that B1
was expressed more efficiently when the B2–134 AUG
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was changed to ACG (threonine) (Fig. 3A and Fig. 3B,
Lanes 4 and 5) suggests that perhaps the B1 AUG is
used inefficiently due to its occlusion by the B2–134
AUG. Nonetheless B1 was detected in wild-type-trans-
fected cell lysates.
Synthesis of nodavirus B1 protein has been confirmed
experimentally for only FHV (Harper, 1994). The B1 ORF
is the 5 proximal ORF on FHV RNA3, yet only low
amounts of this protein are made in FHV-infected Dro-
sophila cells, perhaps because the translational initiation
context is sub-optimal and the AUG that initiates B1 is
only 8 nt from the 5 end (Harper, 1994). Like NoV B1, FHV
B1 (102 aa) migrates aberrantly in SDS–PAGE gels rela-
tive to the larger B2 protein (106 aa). NoV B1 shares only
34% sequence identity with FHV B1 (data not shown), but
both are C-terminal fragments of protein A and both have
unusually high isoelectric points (12.59 for NoV and 12.58
for FHV; data not shown) which may account for their
anomalous mobilities in SDS–PAGE gels.
The functions of NoV B1 and B2 proteins remain un-
known. No role for B1 has been proposed for any of the
nodaviruses examined to date, and BoV and SJNNV lack
this ORF entirely (Harper, 1994; Iwamoto et al., 2001).
NoV B2 mutant 1, which lacked both B2 ORFs, exhibited
wild-type rates of RNA replication in BSR T7/5 cells. We
observed no difference in the rates of RNA1 replication
or RNA3 synthesis, nor any effect on the ability to repli-
cate RNA2 in trans (Fig. 2, Lanes 5 and 9). Similar results
were observed for mutants that removed the B1 ORF,
either singly or together with one or both B2 ORFs (data
not shown), suggesting that RNA replication in BSR T7/5
cells did not require synthesis of proteins B2 or B1.
Similarly, the FHV B1 and B2 proteins are dispensable for
RNA replication in mammalian and yeast cells (Ball,
1995; Eckerle and Ball, 2002; Price et al., 2000), as is PaV
B2 dispensable in mammalian cells (Johnson and Ball,
2001). FHV mutants lacking the B1 ORF replicate in
Drosophila cells and produce wild-type levels of infec-
tious virus (Harper, 1994). In contrast, FHV B2 is neces-
sary for wild-type levels of viral replication in Drosophila
cells (Harper, 1994; Li et al., 2002).
FHV B2 has recently been implicated as a suppressor
of RNA silencing/interference in Drosophila cells and in
plants (Li et al., 2002). The possibility that NoV B2 may
share the RNA silencing suppressor function will be
considered elsewhere.
Summary
In summary, we have reproduced the infectious cycle
of NoV from cDNA clones expressed in mammalian cells.
The tools we describe here will facilitate the study of
NoV RNA replication and pathogenesis, and the devel-
opment of nodavirus-based expression systems.
MATERIALS AND METHODS
Cells and viruses
Baby hamster kidney BHK21 cells were grown at 37°C
as described (Ball et al., 1992), except that the growth
medium used was DMEM supplemented with 5% each
newborn calf serum and fetal bovine serum (FBS). BSR
T7/5 cells (Buchholz et al., 1999) were grown at 37°C in
the same medium, supplemented in alternate passages
with 600 g/ml G-418 (Gibco Invitrogen Corporation), as
described previously (Albarin˜o et al., 2001).
NoV, obtained from the American Type Culture Collec-
tion (ATCC; VR-679, strain Mag115), was propagated in
infected suckling mice and purified from the back and
hind limb musculature as described (Ball et al., 1992;
Newman and Brown, 1973). Alternatively, NoV was prop-
agated in G. mellonella larvae injected with the mouse-
derived virus (Bailey et al., 1975) and gradient-purified as
described for PaV (Johnson et al., 2000). Recombinant
NoV particles derived from the cDNA clones were iso-
lated from G. mellonella larvae infected with a lysate
from transfected BSR T7/5 cells as described below.
Particle concentration was calculated using an extinction
coefficient at a wavelength of 260 nm of 4.15/mg (Long-
worth and Carey, 1976) and particle mass of 8  106
g/mol (Newman and Brown, 1977).
Terminal sequence determination and cDNA
synthesis
Virion RNAs (vRNAs) were extracted from purified NoV
particles as described (Ball et al., 1992; Chomczynski
and Sacchi, 1987). Genomic RNA was used as a tem-
plate for first strand cDNA synthesis by Superscript II
reverse transcriptase (Invitrogen Life Technologies) us-
ing random hexameric primers. NoV1-specific primers
were designed from the sequences of partial NoV RNA1
cDNA clones and used to generate larger cDNAs. 5
terminal RNA1 cDNA clones were generated by 5-RACE
using as a template total cellular RNA from vRNA-trans-
fected BHK21 cells. The same template was used to
generate junction clones of RNA1 and RNA2 by RT-PCR
across 3-5 dimer junctions, as described in Results.
Full-length RT-PCR products were inserted into a plas-
mid vector and 6 independent clones of each were se-
quenced.
Full-length cDNAs of NoV RNA1 and RNA2 were syn-
thesized by RT-PCR using genomic RNA templates and
primers specific for the termini of each, and ligated into
plasmid TVT7R(0,0) (Johnson et al., 2000). The cDNA
inserts of the resulting plasmids, pNoV1(0,0) and
pNoV2(0,0), were sequenced completely along both
strands. These sequences were deposited with Gen-
Bank (Accession numbers AF174533 and AF174534 for
NoV1 and NoV2, respectively).
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Site-directed mutagenesis
The indicated NoV RNA1 mutations were generated by
PCR-based circular mutagenesis followed by DpnI se-
lection, as described (Sambrook and Russell, 2001). In
each case, plasmid pNoV1(0,0) was amplified using Pfu-
Turbo DNA polymerase (Stratagene) and the mutagenic
oligonucleotides detailed below. The regions of interest
were confirmed by sequencing, and small DNA frag-
ments carrying the desired mutations were re-ligated
into the parental plasmid background using standard
techniques (Sambrook and Russell, 2001).
For U1274C, the mutagenic oligonucleotides were
identical to NoV1 nt 1263–1292 and complementary to nt
1285–1251, respectively, except for the indicated change.
Mutations affecting the B2 and/or B1 ORFs (mutants 1–5)
were created using the following mutagenic oligonucle-
otides, which contain the mutations shown in Fig. 4A.
Mutant 1 (B2B1): identical to nt 2724–2768 and com-
plementary to nt 2763–2724, except as indicated. Mutant
2 (B2B1): identical to nt 2724–2762 and complemen-
tary to nt 2763–2724, except as indicated. Mutant 3
(B2B1): identical to nt 2746–2771 and complementary
to nt 2771–2746, except as indicated. Mutant 4
(B2B1): the same oligonucleotides used to create
Mutant 3, but using as a template a pNoV1(0,0) plasmid
containing the mutant 1 sequence rather than the wild-
type. Mutant 5 (B2B1): identical to nt 2724–2771 and
complementary to nt 2771–2724, except as indicated.
Transfection of mammalian cells
Confluent monolayers containing 2  106 BHK21 or
BSR T7/5 cells (per 10 cm2 well) were transfected with 50
ng of purified vRNAs using LipofectAmine or Lipo-
fectAmine 2000 (Invitrogen Life Technologies) as de-
scribed (Albarin˜o et al., 2001). Transfection of plasmid
DNA (2.5 g pNoV1(0,0) or 1 g pNoV2(0,0), either alone
or in combination) into confluent monolayers of BSR T7/5
cells was performed using LipofectAmine 2000, as
above. Incubations were performed at 28°C for 24h
(vRNA transfections) or 48 h (plasmid transfections) prior
to metabolic labeling as below.
RNA labeling, isolation, and analysis
For transfected cells, the products of RNA replication
were labeled by metabolic incorporation of [3H]uridine in
the presence of 20 g/ml actinomycin D as described
(Ball et al., 1992), except that labeling was for 3 h (be-
ginning at 48 h post-transfection for plasmid-transfected
cells and at 24 h for vRNA-transfected cells); under these
conditions, only the products of RNA-dependent RNA
synthesis are labeled. Samples to be analyzed by North-
ern blot hybridization were left unlabeled. In both cases,
total cellular RNAs were isolated (Chomczynski and Sac-
chi, 1987) and analyzed as follows.
PE analysis. RNA samples (corresponding to 13% of a
10 cm2 well) were either left untreated or treated with
tobacco acid pyrophosphatase (TAP; Epicentre Technol-
ogies, Madison, WI) to remove 5 caps and analyzed by
PE. PE products were resolved on 5% polyacrylamide
sequencing gels alongside dideoxynucleotide sequenc-
ing ladders generated using the same primers on
pNoV1(0,0) or pNoV2(0,0) plasmid templates, and visual-
ized by autoradiography as described (Ball, 1995). Oligo-
nucleotide primers complementary to NoV RNA1 (nt 108–
83), RNA2 (nt 102–81), or RNA3 (nt 2837–2812 of RNA1)
were used.
Gel analysis. RNA samples (corresponding to 8% of a
10 cm2 well for plasmid transfections or 4% of a well for
vRNA transfections) were separated on denaturing form-
aldehyde-agarose gels and labeled RNAs were visual-
ized by fluorography using pre-flashed x-ray film, as
described (Ball et al., 1992; Laskey and Mills, 1975). The
relative amounts of the RNA replication products were
quantitated by densitometric scanning of the resulting
fluorographs.
Northern blot analysis. RNA samples (corresponding
to 3.3% of a 10 cm2 well for detection of () strands and
16.5% of a 10 cm2 well for detection of () strands) were
resolved by electrophoresis on denaturing formalde-
hyde-agarose gels, transferred to Nytran nylon mem-
branes (Schleicher and Schuell), and subjected to North-
ern hybridization as described previously (Price et al.,
2000). Strand-specific [32P]-labeled RNA probes for NoV
were generated by in vitro transcription from PCR prod-
ucts containing promoters of bacteriophage-encoded
RNA polymerases (SP6 and T7) as described (Sambrook
and Russell, 2001). Probes for NoV RNA1 and RNA3
contained nt 2732–3204 of the appropriate sense NoV
RNA1. Probes for NoV RNA2 contained nt 1–22 and
1100–1336 of the appropriate sense NoV RNA2. The
results were visualized with a Molecular Dynamics Phos-
phorImager digital radioactivity imaging system. RNA
replication products were quantitated from the resulting
scanned images using ImageQuant software (Amersham
Biosciences Products); only samples falling within the
linear range of the assays were included. For the deter-
mination of positive-to-negative strand ratios, the levels
of RNA accumulation from four independent time course
experiments were averaged over days 4–10. Similar
methods were used to quantitate the endpoint dilution
assays.
Protein analysis
Transfected cells were labeled for 3 h (beginning at
48 h post-transfection for plasmid-transfected cells and
at 24 h for vRNA-transfected cells); by metabolic incor-
poration of [35S]methionine and [35S]cysteine and lysed in
a solution containing 1% NP-40 and 0.4% deoxycholate
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as described previously (Ball et al., 1992). Nuclei were
removed by centrifugation, and proteins were analyzed
described below.
[35S]-labeled NoV virions were prepared by transfec-
tion of 2  107 BSR T7/5 cells with non-recombinant NoV
(Mag115) vRNA and metabolic labeling as above. The
cells were lysed by addition of NP-40 to the medium,
cellular debris was removed by centrifugation, and par-
ticles were pelleted through a 30% sucrose cushion as
described (Johnson et al., 2000).
Gel analysis. Samples corresponding to 4% of a 10 cm2
well were separated on 12.5% polyacrylamide-SDS gels
(Laemmli, 1970) and proteins were visualized by staining
with Coomassie brilliant blue (Sigma) or by autoradiog-
raphy. Background cellular proteins were found to trans-
fer relatively more efficiently to PVDF membranes than
did viral capsid proteins. Therefore autoradiography was
used to visualize labeled NoV proteins remaining in the
gel after the transfer.
Matrix-assisted laser desorption/ionization-time-of-
flight (MALDI–TOF) mass spectrometry. Cell lysates were
concentrated eightfold on Microcon columns with a 3K
MW cutoff (Amicon Bioseparations), and samples corre-
sponding to 4% of a 10 cm2 well were diluted 1:10 with
matrix and 1 l was pipetted onto a smooth plate. Sina-
pinic acid (Aldrich) dissolved in acetonitrile:0.1% TFA (1:1)
was used as the matrix. Samples were analyzed in the
positive mode on a Voyager Elite mass spectrometer
with delayed extraction technology (PerSeptive Biosys-
tems, Framingham, MA). The mass spectrometer was
calibrated with apomyoglobin, which has a molecular
mass of 16952 Da.
Alternatively, proteins from 6% of a 10 cm2 well were
separated on 12.5% polyacrylamide-SDS gels as above,
stained with colloidal Coomassie (GelCode Blue; Pierce),
and the B2 and B1 regions were individually excised
from the gels. The samples were destained by washing
with acetonitrile:25 mM ammonium bicarbonate (1:1) and
dried. The gel-slices were subjected to in-gel proteolysis
by trypsin (Hellman et al., 1995; Rosenfeld et al., 1992).
They were rehydrated with 10 l of 12.5 ng/l trypsin in
25 mM ammonium bicarbonate buffer and digested over-
night at 37°C. After digestion, the peptides were ex-
tracted 3 times with 50 l of acetonitrile:5% formic acid
(1:1). The pooled extracts were dried, redissolved in 10 l
acetonitrile:5% formic acid (1:1), diluted 1:1 with -cyano-
4-hydroxycinammic acid (Aldrich) matrix and spotted
onto a MALDI plate. Samples were analyzed with a
Voyager-DE PRO mass spectrometer (Applied Biosys-
tems). Each sample was calibrated internally with pep-
tide fragments from trypsin autocatalytic digestion. The
experimental tryptic peptide profiles were compared to
the fragments predicted by the sequences of the B1 and
B2 ORFs.
Infection of G. mellonella larvae
Larvae of the greater wax moth, G. mellonella (Caroli-
na Biologicals), were reared at 31°C as described (John-
son et al., 2000). Plasmid-transfected BSR T7/5 cells
were incubated as above and harvested by scraping into
500 l PBSM (phosphate buffered saline containing 1
mM each MgCl2 and CaCl2). Cells were lysed by three
cycles of freezing and thawing and cell debris was re-
moved by centrifugation. Lysates (10 l per insect), either
left untreated or treated with RNaseA, were injected into
the hemocoel of G. mellonella larvae as described for
PaV (Johnson and Ball, 2001), in groups of 12 (average
weight, 70 mg). Injected larvae were incubated with food
at 31°C for 11 days. For purification of recombinant NoV,
incubation was for 8 days and virus particles were iso-
lated as above.
Infection of BHK21 cells with NoV
For the time-course experiments, 2  106 BHK21 cells
were infected in serum-containing growth medium with
1000 particles per cell of authentic, mouse-derived NoV
or of recombinant NoV grown in G. mellonella larvae, and
incubated at 28°C for 12 days. Parallel wells were har-
vested at 24 h intervals and total cellular RNAs were
isolated and analyzed by Northern blot hybridization as
above.
For determination of viral yields from transfected BSR
T7/5 cells, cell lysates were prepared 48 h after trans-
fection by three cycles of freezing and thawing as de-
scribed above, except that cells were harvested in 1 ml
PBSM, then treated with RNaseA. Serial 10-fold dilutions
were prepared in serum-free medium and used to infect
monolayers of 8  104 BHK21 cells. Infection of BHK21
cells in parallel wells with gradient-purified recombinant
NoV, at multiplicities of 2  104, 2  103, 200, or 20
particles per cell, generated a standard curve. After in-
cubation at 28°C for 5 days, total cellular RNAs were
extracted and quantitated by Northern blot hybridization
as above.
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